{"id":2850,"date":"2013-10-16T15:12:58","date_gmt":"2013-10-16T15:12:58","guid":{"rendered":"\/?p=2850"},"modified":"2013-10-16T15:13:11","modified_gmt":"2013-10-16T15:13:11","slug":"amarantus-bioscience-holdings-inc-otcmktsambs-jumps-ahead-of-presentation-to-investors","status":"publish","type":"post","link":"\/articles\/amarantus-bioscience-holdings-inc-otcmktsambs-jumps-ahead-of-presentation-to-investors\/","title":{"rendered":"Amarantus Bioscience Holdings, Inc. (OTCMKTS:AMBS) Jumps Ahead of Presentation to Investors"},"content":{"rendered":"

After a serious streak of days in the red, Amarantus Bioscience Holdings, Inc. (OTCMKTS:AMBS<\/a>) is gaining in the past days, adding 9% on Tuesday to reach $0.0579. Dollar volumes were near $250,000, and on Wednesday, the ticker started up on opening. \"AMBS1016.png\" <\/p>\n

Like many other pharmaceutical stocks, AMBS<\/a> is always boosted by positive news- in this case, a promising test result of Lympro, a blood test for Alzheimer’s disease that is still in the trials stage. The positive research data bring the test a step closer to market, where it would be a one of a kind diagnostic tool. Despite the promise, AMBS<\/a> is still hovering below the 10-cent levels, and for a few months now has been reeling from the unsustainable price achieved during the summer promotions.\"ISCO1016.png\"<\/p>\n

But here comes another boost, an investors’ conference, the other pathway to kindle interest in a biotech stock. AMBS<\/a> will present at 6th annual Livingston Securities Life Science Stakeholders Summit on Thursday, October 17th – and we may expect this would support the price levels.<\/p>\n

A lot of attention heaped on a stock is not always a good thing. An investors’ conference drew attention to International Stem Cell Corp. (OTCMKTS:ISCO<\/a>), jumped temporarily to the peak of the range at 22 cents, but went on to slide to 17 cents immediately after.<\/p>\n

Advanced Cell Technology, Inc. (OTCBB:ACTC<\/a>) has more farfetched claims, though it hovers in a similar range to AMBS<\/a>. The ticker has been stuck again, at around 6 cents in the past few days.<\/p>\n

As for AMBS<\/a>, dollar volumes remain cautious, revealing that this ticker has lost the enthusiastic support riled up by paid promoters. Volumes are erratic, despite the very regular press releases- but some of the news hardly generate attention. Still, the company is burdened by much debt, about $5.5 million, and has no revenues, only accumulating above $15 million losses. The company also has about 460 million shares outstanding, a weighty amount that may drag the shares down.<\/p>\n

Several big names in the pharmaceutical sector are getting more active as presentations and conferences draw attention. Titan Pharmaceuticals, Inc. (OTCBB:TTNP<\/a>) is still struggling to close the gap. So is OncoSec Medical, Inc. (OTCMKTS:ONCS), which recently lost a third of its price on choppy trading.<\/p>\n

If you want exposure to the sector, keep in mind that tickers offer differing qualities, and AMBS<\/a> is among the more speculative bids, relying on future promises to boost the positions. Stay away unless you can afford the fallout.<\/p>\n","protected":false},"excerpt":{"rendered":"

After a serious streak of days in the red, Amarantus Bioscience Holdings, Inc. (OTCMKTS:AMBS) is gaining in the past days, adding 9% on Tuesday to reach $0.0579. Dollar volumes were near $250,000, and on...<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[199,255,238,11],"class_list":["post-2850","post","type-post","status-publish","format-standard","hentry","category-news","tag-actc","tag-ambs","tag-isco","tag-ttnp"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/2850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=2850"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/2850\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=2850"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=2850"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=2850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}